Pharmacokinetics of mycophenolic acid and clinical outcomes in liver transplant recipients with hepatitis C (HCV).

被引：0
|
作者：
Sievers, TM [1 ]
Holt, CD [1 ]
Ghobrial, RM [1 ]
Artinian, L [1 ]
McDiarmid, SV [1 ]
Busuttil, RW [1 ]
机构：
[1] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2004年 / 4卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
762
引用
收藏
页码：365 / 365
页数：1
相关论文
共 50 条
  • [21] Hepatitis C Treatment and Transplant Outcomes in Liver Transplant Recipients with Hepatitis C Positive Donors.
    Booth, I.
    Clark, J.
    LaMattina, J. C.
    Haririan, A.
    Barth, R. N.
    Ravichandran, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 570 - 571
  • [22] Sirolismus in post hepatitis C virus (HCV) liver transplant recipients.
    Marrero, R
    Neff, GW
    Montalbano, M
    Nery, J
    Weppler, D
    Schiff, ER
    Tzakis, AG
    HEPATOLOGY, 2002, 36 (04) : 664A - 664A
  • [23] Pharmacokinetics and protein binding of mycophenolic acid in stable lung transplant recipients
    Ensom, MHH
    Partovi, N
    Decarie, D
    Dumont, RJ
    Fradet, G
    Levy, RD
    THERAPEUTIC DRUG MONITORING, 2002, 24 (02) : 310 - 314
  • [24] Population pharmacokinetics of mycophenolic acid and its determinants in renal transplant recipients
    van Hest, RM
    van Gelder, T
    Vulto, AG
    Mathôt, RAA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (01) : 106 - 107
  • [25] Population pharmacokinetics of mycophenolic acid in senile Chinese kidney transplant recipients
    Wang, C. X.
    Meng, F. H.
    Chen, L. Z.
    Ren, B.
    Li, S. X.
    Fei, J. G.
    Qiu, J.
    Deng, S. X.
    Li, J.
    Chen, S. Y.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (05) : 1392 - 1395
  • [26] Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors
    Cotter, Thomas G.
    Paul, Sonali
    Sandikci, Burhaneddin
    Couri, Thomas
    Bodzin, Adam S.
    Little, Ester C.
    Sundaram, Vinay
    Charlton, Michael
    HEPATOLOGY, 2019, 69 (06) : 2381 - 2395
  • [27] Hepatitis c (HCV) genotyping of cardiac transplant recipients
    Lake, KD
    Smith, CI
    Germer, J
    Persing, DH
    Pritzker, MR
    Emery, RW
    HEPATOLOGY, 1996, 24 (04) : 583 - 583
  • [28] URINARY ABNORMALITIES IN HEPATITIS-C (HCV) POSITIVE LIVER-TRANSPLANT RECIPIENTS
    DAVIS, CL
    WARTELLE, CF
    SHUHART, MC
    GRETCH, DR
    CARITHERS, RL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 1000 - 1000
  • [29] OUTCOMES OF HEART-TRANSPLANT (HTX) RECIPIENTS INFECTED WITH HEPATITIS-C (HCV)
    LAKE, KD
    SMITH, CI
    MILFRED, SK
    PRITZKER, MR
    EMERY, RW
    HEPATOLOGY, 1995, 22 (04) : 964 - 964
  • [30] Circadian pharmacokinetics of mycophenolic acid and implication of genetic polymorphisms for early clinical events in renal transplant recipients
    Satoh, Shigeru
    Tada, Hitoshi
    Murakami, Miho
    Tsuchiya, Norihiko
    Li, Zhenhua
    Numakura, Kazuyuki
    Saito, Mitsuru
    Inoue, Tadamitsu
    Miura, Masatomo
    Hayase, Yukitoshi
    Suzuki, Toshio
    Habuchi, Tornonori
    TRANSPLANTATION, 2006, 82 (04) : 486 - 493
12345